April 22, 2019, Medical News Today 

Leucine, an amino acid that the body needs for making protein, appears to have a surprising role in the development of resistance to tamoxifen in breast cancer that tests positive for the estrogen receptor. Scientists from Harvard Medical School recently made this "unexpected" discovery about estrogen receptor-positive breast cancer in a study conducted with colleagues from other research centers. 

Read more.

April 22, 2019, Contemporary Clinic  

The first and only FDA-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral daily capsule for the treatment of moderate-to-severe vasomotor symptoms, BijuvaTM, from Therapeutics MD is now commercially available in the U.S., according to a press release from the company. Bijuva offers a proven balance of bio-identical estradiol combined with bio-identical progesterone to reduce risk to the endometrium in women with a uterus, according to the release. 

Read more.

April 19, 2019, MedPage Today  

A type of cervical cancer often missed by Pap testing was seen at increasing rates over the past 15 years in the U.S., whereas rates of the most common histology decreased, a review of a cancer database showed. 

Read more.

April 19, 2019, Infectious Disease News 

The monoclonal antibody UB-421 “demonstrated unprecedented and sustained” virologic suppression in the absence of ART among people with HIV during a nonrandomized, open-label, phase 2 clinical study, according to findings published April 17 by The New England Journal of Medicine.

Read more.

April 16, 2019, Lupin

Lupin Pharmaceuticals Medical Affairs is looking for PAs in ObGyn and Women’s Health to participate in an advisory board meeting on the topic of bacterial vaginosis (BV).  This meeting will take place during, but not affiliated with, the AAPA 2019 Annual Meeting in Denver.  An honorarium will be offered for your time.

The meeting will be held Tuesday, May 21, 6-8pm at the Hyatt Regency Denver. (Dinner will be served)

Please contact Elizabeth Sarkar at sarkar@ja-online.com if you are interested or for more information.

April 15, 2019
Submitted by APAOG Publications Chair Heather Adams 

Endocrine Society Guidelines 

The Endocrine Society recently used clinical trial data and clinical expertise to formulate new guidelines for the treatment of postmenopausal osteoporosis. 

Read more.

PAs and Medical Malpractice Claims

A new trend has been identified; Physician Assistants are being increasingly targeted or singled out by the Personal Injury Bar for medical malpractice claims.  

Read more. 

FDA Approves expanded us of Gardasil9® 

It’s official! The FDA has approved the expanded age indication for Gardasil 9®, which is now indicated for females and males from age 9 years to 45 years of age.  

  

Read more.

April 15, 2019, HemOnc Today 

HPV infection drove a recent increase in glottic carcinoma incidence among individuals aged 30 years and younger, according to results of a retrospective study published in in Annals of Otology, Rhinology & Laryngology. 

Read more.

April 15, 2019, MedPage Today OB/GYN Update  

Women ages 50 to 74 at average risk for breast cancer should undergo screening mammography every other year, according to the latest guidance from the American College of Physicians (ACP), recommendations that were met with immediate pushback from the radiology community. 

Read more. 

April 12, 2019, Infectious Disease News via Healio  

The IV formulation of fosfomycin was found to be effective in treating complicated UTIs, including acute pyelonephritis, compared with IV piperacillin-tazobactam, according to research published in Clinical Infectious Diseases. 

Read more.

April 10, 2019, MedPage Today

WASHINGTON -- The FDA approved romosozumab (Evenity) for osteoporosis in postmenopausal women at high risk for fracture, the agency announced Tuesday. 

Read more.